Nevro Long Term Debt 2013-2024 | NVRO
Nevro long term debt from 2013 to 2024. Long term debt can be defined as the sum of all long term debt fields.
| Nevro Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $211 |
| 2022 | $187 |
| 2021 | $151 |
| 2020 | $142 |
| 2019 | $160 |
| 2018 | $152 |
| 2017 | $145 |
| 2016 | $138 |
| 2015 | $20 |
| 2014 | $20 |
| 2013 | $ |
| 2012 | $ |
| Nevro Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-06-30 | $181 |
| 2024-03-31 | $215 |
| 2023-12-31 | $211 |
| 2023-09-30 | $188 |
| 2023-06-30 | $187 |
| 2023-03-31 | $187 |
| 2022-12-31 | $187 |
| 2022-09-30 | $187 |
| 2022-06-30 | $186 |
| 2022-03-31 | $186 |
| 2021-12-31 | $151 |
| 2021-09-30 | $149 |
| 2021-06-30 | $146 |
| 2021-03-31 | $144 |
| 2020-12-31 | $142 |
| 2020-09-30 | $140 |
| 2020-06-30 | $137 |
| 2020-03-31 | $162 |
| 2019-12-31 | $160 |
| 2019-09-30 | $158 |
| 2019-06-30 | $156 |
| 2019-03-31 | $154 |
| 2018-12-31 | $152 |
| 2018-09-30 | $151 |
| 2018-06-30 | $149 |
| 2018-03-31 | $147 |
| 2017-12-31 | $145 |
| 2017-09-30 | $143 |
| 2017-06-30 | $142 |
| 2017-03-31 | $140 |
| 2016-12-31 | $138 |
| 2016-09-30 | $136 |
| 2016-06-30 | $135 |
| 2016-03-31 | $20 |
| 2015-12-31 | $20 |
| 2015-09-30 | $20 |
| 2015-06-30 | $20 |
| 2015-03-31 | $20 |
| 2014-12-31 | $20 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.199B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.467B | 25.92 |
| Intuitive Surgical (ISRG) | United States | $180.733B | 94.49 |
| Alcon (ALC) | Switzerland | $45.462B | 32.00 |
| Edwards Lifesciences (EW) | United States | $40.042B | 24.90 |
| IQVIA Holdings (IQV) | United States | $38.149B | 21.02 |
| IDEXX Laboratories (IDXX) | United States | $33.943B | 39.97 |
| DexCom (DXCM) | United States | $27.225B | 41.00 |
| Waters (WAT) | United States | $22.999B | 34.01 |
| STERIS (STE) | Ireland | $22.270B | 25.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.961B | 0.00 |
| Hologic (HOLX) | United States | $19.446B | 20.52 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.766B | 13.19 |
| Sysmex ADR (SSMXY) | Japan | $11.599B | 36.37 |
| Globus Medical (GMED) | United States | $10.118B | 28.30 |
| Teleflex (TFX) | United States | $9.629B | 15.36 |
| Penumbra (PEN) | United States | $8.808B | 86.28 |
| Masimo (MASI) | United States | $7.841B | 41.99 |
| Glaukos (GKOS) | United States | $7.219B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.065B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.244B | 24.06 |
| Inari Medical (NARI) | United States | $2.865B | 0.00 |
| TransMedics (TMDX) | United States | $2.852B | 90.39 |
| Veracyte (VCYT) | United States | $2.687B | 166.57 |
| LivaNova (LIVN) | United Kingdom | $2.661B | 15.36 |
| Nihon Kohden (NHNKY) | Japan | $2.561B | 15.94 |
| Elekta AB (EKTAY) | Sweden | $2.323B | 18.92 |
| Tandem Diabetes Care (TNDM) | United States | $2.151B | 0.00 |
| RxSight (RXST) | United States | $1.896B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.871B | 9.73 |
| Alphatec Holdings (ATEC) | United States | $1.185B | 0.00 |
| Artivion (AORT) | United States | $1.150B | 105.61 |
| OPKO Health (OPK) | United States | $1.032B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.934B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.883B | 15.01 |
| OrthoPediatrics (KIDS) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.684B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.662B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.641B | 16.18 |
| IRadimed (IRMD) | United States | $0.626B | 33.81 |
| AxoGen (AXGN) | United States | $0.622B | 0.00 |
| SiBone (SIBN) | United States | $0.568B | 0.00 |
| Paragon 28 (FNA) | United States | $0.506B | 0.00 |
| CVRx (CVRX) | United States | $0.365B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.359B | 19.62 |
| ClearPoint Neuro (CLPT) | United States | $0.352B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.338B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.299B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.274B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.214B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.210B | 14.62 |
| NeuroPace (NPCE) | United States | $0.186B | 0.00 |
| Accuray (ARAY) | United States | $0.180B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.122B | 0.00 |
| 908 Devices (MASS) | United States | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 15.51 |
| EDAP TMS S.A (EDAP) | France | $0.100B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.086B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.062B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.044B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |